PhosPrint is a laser bioprinter developer focusing on the highly precise and rapid delivery of cells and other bio-inks on the substrates of interest for tissue regeneration, printed diagnostics and biosensor applications.
Latest news
events | press releases | media coverage
28.10.20
PhosPrint is proud to announce its participation in the EU funded project “UroPrint” under the H2020-FETOPEN-2018-2020 call
19.08.20
PhosPrint is proud to announce its participation in the EU funded project “Tumor-LN-oC” under the H2020 NMBP-23-2020 call
24.02.20
Our co-founder and CTO Ioanna Zergioti was awarded with the 3D printing award at SPIE Photonics West 2020, 3 February in San Francisco as a recognition for the fundamental work in the development of a single step laser bioprinting and immobilization process that offers a significant step towards research of cell properties confined in scaffold environments.
09.01.20
PhosPrint qualifies for the semi-finals of the SPIE Startup Challenge 2020 at the SPIE Photonics West Conference!
09.12.19
PhosPrint awarded with the Proof of Concept (PoC) Award from Patras Science Park.
28.03.19
PhosPrint receives the Seal of Excellence from the European Commission, for its high-quality project proposal, in a highly competitive evaluation process, submitted under the Horizon 2020 SME Instrument Phase 1 call H2020-EIC-SMEInst-2018-2020 (H2020-SMEInst-2018-2020-1)
Contact
Phos Print
Lefkippos Technology Park, NCSR Demokritos
Patriarchou Grigoriou 5’ & Neapoleos 27
153 41, Agia Paraskevh, Athens, Greece
Tax Registration Number: 801099345
General Electronic Commercial Registry (GEMI)
Nr: 149072501000